Impaired Proliferation of CD8+ T Cells Stimulated with Monocyte‐Derived Dendritic Cells Previously Matured with Thapsigargin‐Stimulated LAD2 Human Mast Cells
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2024 (1) , 5537948
Abstract
CD8+ T cells are essential for adaptive immunity against infection and tumors. Their ability to proliferate after stimulation is crucial to their functionality. Dendritic cells (DCs) are professional antigen‐presenting cells that induce their proliferation. Here, we show that thapsigargin‐induced LAD2 mast cell (MC) line‐released products can impair the ability of monocyte‐derived DCs to induce CD8+ T‐cell proliferation and the generation of Th1 cytokine‐producing T cells. We found that culture medium conditioned with LAD2 MCs previously stimulated with thapsigargin (thapsLAD2) induces maturation of DCs as determined by the maturation markers CD80, CD83, CD86, and HLA‐DR. However, thapsLAD2‐matured DCs produced no detectable TNFα or IL‐12 during the maturation. In addition, although their surface expression of PD‐L1 was comparable with the immature or TLR7/8‐agonist (R848)‐matured DCs, their TIM‐3 expression was significantly higher than in immature DCs and even much higher than in R848‐matured DCs. In addition, contrary to R848‐matured DCs, the thapsLAD2‐matured DCs only tended to induce enhanced proliferation of CD4+ T cells than immature DCs. For CD8+ T cells, this tendency was not even detected because thapsLAD2‐matured and immature DCs comparably induced their proliferation, which contrasted with the significantly enhanced proliferation induced by R848‐matured DCs. Furthermore, these differences were comparably recapitulated in the ability of the tested DCs to induce IFNγ‐ and IFNγ/TNFα‐producing T cells. These findings show a novel mechanism of MC‐mediated regulation of adaptive immune responses.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (AZV NU22-03-00300, NU23-08-00071)
This publication has 98 references indexed in Scilit:
- Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy targetClinical and Translational Medicine, 2023
- Classical DC2 subsets and monocyte‐derived DC: Delineating the developmental and functional relationshipEuropean Journal of Immunology, 2023
- SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donorsImmunity, Inflammation and Disease, 2021
- BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patientsClinical & Translational Immunology, 2020
- Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programmingThe EMBO Journal, 2014
- The Mechanisms of Exocytosis in Mast Cells2011
- The critical role of Th1-dominant immunity in tumor immunologyCancer Chemotherapy and Pharmacology, 2000
- Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cellsEuropean Journal of Immunology, 1996
- Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNF‐α, but strongly enhanced by interleukin‐10European Journal of Immunology, 1995
- Thapsigargin, a novel molecular probe for studying intracellular calcium release and storageInflammation Research, 1989